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We present a report regarding the cytotoxic effects of iron-based magnetic 
nanoparticles conjugated with fluorodeoxyglucose (FDG-mNPs) on the 
viability of NCI-H727 and SH-SY5Y cancer cells. MTT assays were performed 
to determine cell viability in treated cancer cells grown under standard 2D 
culture conditions. FDG-mNP concentrations of 0.075 mg/mL, 0.15 mg/mL, 
and 0.3 mg/mL decreased mean cell viability of NCI-H727 cells to 92.5%, 
82.9%, and 75% respectively. FDG-mNPs was also shown to have a 
detrimental effect on the viability of SY5Y cells: a decrease of 5.7%, 18.6%, 
and 36.4% was found for SY5Y cells treated with 0.075 mg/mL, 0.15 mg/mL, 
and 0.3 mg/mL concentrations of FDG-mNPs, respectively. When NCI-H727 
and SH-SY5Y cancer cells were grown as 3D spheroids, morphology was 
visibly changed and the number of viable cells was decerased in spheroids 
treated with FDG-mNPs compared with untreated spheroids. The results of 
our study demonstrated that FDG-mNP has toxic effects on NCI-H7272 and 
SY5Y cancer cells, and we conclude that conjugated FDG-mNPs are promising 
in the development of clinical applications for the destruction of cancer cells. 
© 2021 by SPC (Sami Publishing Company), Asian Journal of Nanoscience and  














Nanoparticles typically have a dimension of 
≤100 nm. They can be made from a range of 
materials including biological materials (viral), 
lipids, polymers, and inorganic materials (metal 
and quantum dots) [1]. Nanoparticles can be 
modified to deliver anti-cancer drugs and to be 
used as imaging probes. Nanoparticles have an 
enormous impact in the field of medical science, 
particularly for drug screening and drug 
delivery.  
Drug delivery with nanoparticles first 
reached a phase I clinical trial in 1985, and the 
first nanoparticles involving doxorubicin 
reached the pharmaceutical market in the mid-
1990s [2]. Since then, at least ten 
nanomedicines have been approved by the 
United States Food and Drug Administration 
[3]. One of the main reasons they are an 
attractive avenue for drug delivery is that they 
have a large functional surface that is capable of 
binding, absorbing, and carrying other particles 
including drugs [4]. For cancer therapy, the use 
of nanoparticles leads to improved drug 
solubility and decreased systemic toxicity in 
comparison with chemotherapy [5]. 
Nanoparticles can also evade the immune 
system due to their size [6]. Recently, 
fluorodeoxyglucose-conjugated magnetic 
nanoparticles (FDG-mNPs) have been shown to 
be effective in the targeting of neuroblastomas 
[7]. The conjugation of mNPs with the glucose 
analogue fluorodeoxyglucose (FDG) is thought 
to improve mNP cellular “incorporation and 
cytotoxicity in cancer cell lines. It is well known 
that cancer cells have a great affinity for glucose 
uptake due to the Warburg effect [8, 9], and FDG 
is a glucose analogue that is rapidly taken up by 
cancer cells [7, 10]. Meanwhile, metal and 
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magnetic nanoparticles themselves induce 
apoptosis in cancer cells. For drug screening, 
the surface of nanoparticles can be changed (e.g. 
crosslinked with glucose or antibodies) to 
efficiently target cancer sites [11]. To study if 
FDG-mNPs successfully enter cancer cells via 
endocytosis, the Hydroxy Dynasore inhibitor 
which inhibits clathrin-mediated endocytosis 
can be used [12]. Additionally, as 2D cell 
cultures have been shown not to represent the 
native environment of tumors, 3D cell culture 
can be utilized alongside a 2D cell culture for a 
more robust analysis. 3D cell cultures have 
similar gradients to tumors which make them 
excellent candidates for drug screening [13]. 
The objective of the present study was to 
determine whether FDG-mNPs can exert 
cytotoxic effects on NCI-H727 and SH-SY5Y 
cancer cells.  
Experimental 
The reagents used were purchased at the 
highest purity available as described below. 
FeCl3, (3-aminopropyl) triethoxysilane 
(APTES), cysteamine, tetraethyl orthosilicate 
(TEOS), Dowex 50 cation exchange resin, 
Amberlite anion exchange resin, C18 pre-
cartridge, cellulose coated TLC sheets, and MTT 
(3-[4,5-dimethylthiazol-2-yl]-2,5-
diphenyltetrazoliumbromide) were purchased 
from Sigma-Aldrich (Missouri, USA). Na2SO3, 
dimethylformamide, N-hydroxysuccinimide, 
Kryptofix, NaF, NH3 were obtained from Merck 
(Darmstadt, Germany). Mannose triflate, K2CO3, 
and Ambersep 900 quaternary ammonium 
anion exchange resin were obtained from Fluka 
(Buchs, Switzerland). Fasentin and Hydroxy 
Dynasore were obtained from TOCRIS 
Bioscience (Abingdon, UK). Propidium iodide 
was purchased from Invitrogen Thermofisher 
Scientific (Waltham, MA, USA). The human lung 
non-small cell carcinoma cell line NCI-H727 was 
obtained from the European Collection of 
Authenticated Cell Cultures (ECACC94060303). 
The human neuroblastoma cell line SH-SY5Y 
was obtained from the European Collection of 
Authenticated Cell Culture (ECACC94030304) 
from a 4-year old child with neuroblastoma. The 
following equipment was used for experimental 
processes: a dynamic light scattering device 
(Malvern Nano ZS DLS, Malvern, UK), a scanning 
electron microscope (SEM) (Thermo Fisher 
Scientific QUANTA 250, FEG, Massachusetts, 
USA), a plate reader (Biotek, Elx800 Universal 
Absorbance Microplate Reader, USA), a 
widefield microscope (Leica Microsystems, 
Germany), a haemocytometer (Carl Zeiss, Jena 
Germany), and an EVOS XL imaging system 
(Thermofisher, UK). 
Synthesis and characterization of FDG-mNPs 
MNPs were synthesized, silica-coated, and 
fabricated with tetraethyl orthosilicate (TEOS). 
The modified mNPs were conjugated with non-
radiactive F using NaF. mNPs and FDG-mNPs 
characterized similarly as described in our 
previous reports [10, 14, 15, 16]. Briefly, the 
hydrodynamic diameter of mNPs or FDG-mNPs 
was measured using DLS. For this, mNPs or 
FDG-mNPs were dispersed in 20% dextrose 
solution at a concentration of 100 µg mL−1 and 
then measured at 25 °C. Measurements were 
repeated three times, and the results were 
expressed as the mean ± standard deviation. 
Particle size and morphology of the synthesized 
mNPs and FDG-mNPs were obtained using SEM.  
In vitro studies  
Cell lines  
The cell lines were cultured at Roswell Park 
Memorial Institute 1640 (RPMI, Sigma- Aldrich, 
USA) and were supplemented with 1% (v/v) L-
Glutamine, 1% (v/v) Penicillin-Streptomycin. 
An additional 10% (v/v) heat inactivated foetal 
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bovine serum was added to the media. The cells 
were cultured in 75 cm3 T-flasks. The flasks 
were incubated under normal conditions (37 ℃, 
5% CO2, and 95% humidity). Before reaching 
confluence, the cell media was changed every 2 
days. Cells were passaged when they reached 
80%–90% confluence with 2.5 mL trypsin-
EDTA (Sigma-Aldrich, USA) for 5–8 minutes. 
The actions of trypsin-EDTA were inhibited by 
using 2.5 mL of RPMI-1640 media. The NCI-
H727 cells were centrifuged at 700 g and the 
SH-SY5Y cells were centrifuged at 1000 g for 5 
min in order to obtain a pellet of cells for each 
of these cell lines. Each pellet of cells was re-
suspended in 5 mL media. The number of cells 
in suspension for the NCI-H7272 cell line was 
determined using a haemocytometer with the 
aid of a microscope (Zeiss model) and a manual 
counter. 
MTT assay 
In order to investigate the effects of FDG-
mNPs on the viability of NCI-H727 and SH-SY5Y 
cells, both cell lines (NCI-H727 and SH-SY5Y) 
were seeded separately into 96-well plates at 
35,000 cells per well. Once seeded, the plates 
were incubated under normal cell culture 
conditions (37 °C, 5% CO2, and 95% humidity) 
for 24 h to ensure that the cells adhere to the 
wells before FDG-mNP treatment. FDG-mNPs 
were pipetted into each well at a volume of 
0.075 mg/mL, 0.15 mg/mL, or 0.3 mg/mL. Glass 
beads and/or phosphate buffered saline (PBS) 
in 200 µL RPMI media were also introduced into 
a portion of the wells. The 96-well plates were 
incubated under normal cell culture conditions 
(37 ℃, 5% CO2, and 95% humidity) for an 
additional period of 24 h. After the 24 h 
incubation period, the 96-well plates were 
washed with PBS. Subsequently, 200 µL of RPMI 
media was added to each well followed by 10 µL 
of MTT solution dissolved in 5 mg/mL of PBS, 
and then the 96-well plates were further 
incubated for 4 h under normal cell culture 
conditions (37 ℃, 5% CO2, and 95% humidity). 
After incubation, absorbance was read at 590 
nm using the Biotek plate reader. 
The same procedure was used for 1 µM, 0.5 
µM, 0.25 µM, and 0.125 µM FDG-mNP 
concentrations and PBS and cell-only wells. 
Absorbance values were converted into 





𝑥10             (1) 
Spheroid generation 
Corning plates (Corning®, USA) were used 
to seed 20,000 cells from the NCI-H727 and 
HTR-8 cell lines. RPMI media supplemented 
with 5% FBS, 1% Penicillin/Streptomycin, and 
1% L-Glutamine were used to ensure a final 
volume of 100 μL. The Corning plates were 
incubated under normal cell culture conditions 
(37 ℃, 5% CO2, and 95% humidity) for 24 h to 
permit formation of spheroids between 200 and 
500 μm in size. This was determined using 
Feret’s diameter function found in ImageJ.  
Morphological evaluation of untreated spheroids 
To determine whether treated spheroids 
have reduced cell viability, first, NCI-H727 
spheroids with appropriate morphology were 
first selected. Spheroid images of spheroids 
before any treatment were obtained using the 
EVOS XL imaging system. The free hand toold 
within the Fiji open-source image processing 
package [17] which consists of the ImageJ 
software with several extra plugins was used 
produce binary masks of the spheroid images. 
The EVOS XL images were also imported to 
Reconstruction and Visualisation from a Single 
Projection (ReVISP), an open-source software 
[18] that enables the visualization of the 3D 
projection of spheroids. ReVISP was used to 
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reconstruct the three-dimensional shape of 
spheroids. The reconstructed images were also 
imported into ImageJ software [19] and, with 
Macro S1 [20, 21], three morphological 
quantitative parameters were assessed: 
solidity, roundness, and sphericity. The solidity 
parameter was assessed using the ImageJ 
“solidity” function which measures the surface 
regularity of spheroids; if spheroids had values 
between 0.90–1, they were considered to have 
a regular rather than irregular surface [22]. The 
roundness parameter was assessed using the 
ImageJ “roundness” function which measures 
how close the spheroid image is to a circle. The 
sphericity parameter was assessed using the 
ImageJ “circularity” function which measures 
the spheroid’s closeness to a spherical 
geometry shape in accordance with equations 





According to Zanoni et al, SI values can be 
categorised as spherical (SI≥0.90) or non-
spherical (SI<0.90) [23]. Spheroids selected for 
treatment with FDG-mNPs were those that 
were determined to be spherical (SI>0.90). 
Treatment of spheroids with FDG-mNP with or 
without hydroxy dynasore 
In order to examine whether FDG-mNP 
treated cells are transported into cancer cells 
via endocytosis, selected NCI-H727 spheroids 
were treated with Hydroxy Dynasore, an 
endocytosis inhibitor. Hydroxy Dynasore was 
solubilized in DMSO to create a 5 mM stock 
solution. The NCI-H727 spheroids were treated 
with Hydroxy Dynasore and incubated for 1 h 
under normal cell culture conditions (37 ℃, 5% 
CO2, and 95% humidity). After 1 h, the 
spheroids were subjected to a concentration of 
0.3 mg/mL of FDG-mNPs and incubated for a 
further 1 h under normal cell culture conditions. 
Following the additional incubation period, the 
spheroids were imaged with the EVOS XL 
imaging system and fixed with 1X fixative 
solution.  
Treatment of Spheroids with FDG-mNP with or 
without fasentin 
Additionally, in order to examine whether 
FDG-MNP treated cells are transported into 
cancer cells via GLUT-1 transporters, selected 
NCI-H727 spheroids were treated with fasentin, 
a GLUT-1 inhibitor. Fasentin was solubilized in 
DMSO to create a 10 mM stock solution. NCI-
H727 spheroids were treated with fasentin to a 
final concentration of 5 mM per well and 
incubated for 1 h under standard cell culture 
conditions (37 ℃, 5% CO2, and 95% humidity). 
After 1 h, the spheroids were treated with FDG-
MNPs at a concentration of 0.3 mg/mL and 
incubated for a further 1 h under normal cell 
culture conditions. Finally, the spheroids were 
imaged with the EVOS XL imaging system and 
fixed using 1X fixative solution. 
Staining and image analysis of treated spheroids 
Propidium iodide is a stain that penetrates 
the nucleus of dead cells to produce a red colour 
at 493 nm. Prior to staining with propridium 
iodide, treated spheroids were washed with 
PBS. Thereafter, they were stained for 10 min. 
Images were obtained using the Widefield 
microscope, with red fluorescence observed in 
dead cells within the spheroids. Images were 
acquired using the Widefield microscope for 
untreated spheroids, FDG-mNPs treated 
spheroids, and FDG-mNP plus Hydroxy 
Dynasore treated spheroids. Subsequently, in 
ImageJ software, the corrected total cell 
fluorescence (CTCF) was calculated using the 
formula Area×Intensity Density−Background to 
a)      𝐶𝑖𝑟𝑐𝑢𝑙𝑎𝑟𝑖𝑡𝑦 =
4𝑟𝑟  𝑥  𝐴𝑟𝑒𝑎
𝑃𝑒𝑟𝑖𝑚𝑒𝑡𝑒𝑟 2
      1 
b)          𝑆𝑝ℎ𝑒𝑟𝑖𝑐𝑖𝑡𝑦 𝐼𝑛𝑑𝑒𝑥 = 𝒋𝐶𝑖𝑟𝑐𝑢𝑙𝑎𝑟𝑖𝑡𝑦 2 
a)      𝐶𝑖𝑟𝑐𝑢𝑙𝑎𝑟𝑖𝑡𝑦 =
4𝑟𝑟  𝑥  𝐴𝑟𝑒𝑎
𝑃𝑒𝑟𝑖𝑚𝑒𝑡𝑒𝑟 2
      1 
b)          𝑆𝑝ℎ𝑒𝑟𝑖𝑐𝑖𝑡𝑦 𝐼𝑛𝑑𝑒𝑥 = 𝒋𝐶𝑖𝑟𝑐𝑢𝑙𝑎𝑟𝑖𝑡𝑦 2 
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determine the number of viable cells and the 
resulting data was imported into a Microsoft 
Excel workbook.  
Statistical analysis 
Statistical analysis was carried out using 
Prism software (GraphPad, Inc., La Jolla, 
California, USA). Statistical analyses included 
one-way and two-ANOVA alongside post hoc 
Tukey’s Test. 
Results and Discussion  
Structural properties of mNPs and FDG-mNPs 
According to DLS measurement, the 
nanoparticles were homogeneously dispersed 
in dextrose (80% water, 20% dextrose) solution 
and had a medium size of 176.7±4.7 nm (n=5) 
together with their hydrodynamic radius. The 
surface potential of mNPs and FDG-mNPs was 
measured to be −4.77±0.918 mV and 
21.26±0.862 mV, respectively. The increased 
surface potential of FDG-mNPs at the 
physiologically relevant pH 7.4 suggests good 
colloidal stability of FDG mNPs.  
SEM images showed that FDG-mNPs had a 
mean size of 10–20 nm and a cubic spinel 
structure (Figure 1). Meanwhile, mNPs 
possessed a particle shape that was a uniform 
homogeneous cubic crystal structure, with a 
particle size of around 20–30 nm.  
Overall, the structural properties of 
synthesized mNPs and FDG-mNPs are in line 
with findings from previous studies [7, 14, 15, 
16]. 
 
Figure 1. SEM image of FDG-mNPs 
Cell viability of FDG-mNP treated NCI-H727 and 
SH-SY5Y cells grown in 2D culture 
Exposure of NCI-H727 and SH-SY5Y cells to 
FDG-mNP at 0.075 mg/mL, 0.15 mg/mL, and 0.3 
mg/mL concentrations led to decreased mean 
cell viability in both cell lines (Figure 2). As 
expected, higher FDG-mNP concentrations led 
to higher decreases in mean cell viability for 
both cell lines (e.g., by 5.7%, 18.6%, and 36.4%, 
for SH-SY5Y cells exposed to 0.075 mg/mL,15 
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mg/mL, and 0.3 mg/mL FDG-mNPs, 
rsepectively). Mean cell viability of NCI-H727 
cells+0.3 mg/mL FDG-mNPs was significantly 
different compared with that of NCI-H727 
cells+glass beads+0.3 mg/mL FDG-mNPs (p < 
0.01) or NCI-H727+PBS+0.3 mg/mL FDG-mNPs 
(p<0.05). Mean cell viability of SH-SY5Y 
cells+0.3 mg/mL was also significantly different 
when compared with that of SH-SY5Y+glass 
beads and 0.3 mg/mL (p<0.0001) and SH-SY5Y 
+PBS+0.3 mg/mL FDG-mNPs. At lower FDG-
mNP concentrations, mean cell viability of SH-
SY5Y cells+0.15 mg/mL FDG-mNPs was 
significantly different when compared with SH-
SY5Y+glass beads+0.15 mg/mL FDG-mNPs and, 
and SH-SY5Y+PBS+0.15 mg/mL FDG-mNPs and 
(p<0.05). 
 
Figure 2. Cell viability percentages of NCI-H727 and SH-SY5Y cells after treatment with FDG-mNPs. 
Charts displaying cell survival percentages of NCI-H727 and SH-SY5Y cells treated with increasing 
concentrations of FDG-mNPs (0.075 mg/mL, 0.15 mg/mL, 0.3 mg/mL). Where bars are labeled as 
“NCI/SY5Y only,” samples contained NCI/SY5Y and RPMI-1640. Bars labeled as “NCI/SY5Y+PBS” 
represent samples that contained cells and PBS only. Samples labeled as “NCI/SY5Y+ GB” represent 
samples containing cells, PBS, and glass beads (1% w/v). Data expressed represent mean values±SD 
from independent experiments performed in triplicate (n=3). **** p<0.0001, ** p<0.01, * p<0.05; 
one-way ANOVA with correction using Tukey’s Test 
Morphology and cell viability of FDG-mNP and 
hydroxy dynasore treated NCI-H727 spheroids 
As shown in Figure 3, as seen on images 
obtained with the EVOS XL microscope, 
morphology was visibly changed in the 
spheroid when treated with FDG-mNPs only 
and when treated with both FDG-mNPs and 
Hydroxy Dynasore, compared with the 
untreated spheroid. When quantitative 
morphological parameters were assessed, 
roundness and SI were decreased in the 
spheroid when treated with FDG-mNPs only 
(roundness=0.7, SI=0.7) and when treated with 
both FDG-mNPs and Hydroxy Dynasore 
(roundness=0.8, SI=0.5), compared with the 
untreated spheroid (roundness=1.0, SI=0.9). 
Whie solidity decreased slightly, all spheroids, 
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whether treated or untreated, were found to 
have a regular spheroid surface (solidty=0.90–
1). There was not enough data to detect 
significant differences in quantitative 
parameters using two-way ANOVA.  
 
Figure 3. Analysis of morphological changes to NCI-H727 spheroids after FDG-mNP treatment and 
Hydroxy Dynasore treatment. A) Spheroids with an appropriate sphericity index (SI) were selected 
and treated with FDG-mNPs, with or without Hydroxy Dynasore 24 hours prior to FDG-mNP 
treatment, and an EVOS XL microscope was used to obtain images. B) Spheroids were reconstructed 
using the ReVISP software (https://sourceforge.net/projects/revisp/). C) Quantitative 
morphological information of the spheroids, including sphericity index (SI), roundness, and solidity. 
ImageJ software (https://imagej.net/) was used along with Macro S1 for the calculation of 
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morphological parameters. Samples labeled as “control” received no treatment, samples labeled as 
“FDG-MNPs” were treated with FDG-mNPs only, and samples labeled as “Hydroxy Dynasore” were 
treated with Hydroxy Dynasore prior to FDG-mNP treatment 
When evaluating cell viability changes in 
spheroids when treated with FDG-mNPs with or 
without Hydroxy Dynasore, exposure of NCI-
H727 cells to 0.3 mg/mL FDG-mNPs with and 
without Hydroxy Dynasore decreased CTCF, 
confirming that there are fewer viable cells for 
treated cells compared with untreated cells 
(Figure 4). The reason that CTCF values are 
negative for both Hydroxy Dynasore and FDG-
mNP might be the under-or over-exposure of 
the fluorescence images.  
 
Figure 4. Fluorescence microscopy of NCI-H727 and corrected total cell fluorescence (CTCF). NCI-
H727 cells were cultured for 24 hours to allow formation of spheroids and were treated with A) FDG-
mNPs only or B) FDG-mNPs and Hydroxy Dynasore. The resulting spheroids were stained with 
propidium iodide solution (nucleus of dead cells appear red) in 100 mL of media for 10 minutes. 
Images were acquired using a Widefield microscope at 493 nm. C) CTCF was calculated using the 
formula Area×Intensity Density–Background using the ImageJ software 
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Morphology and cell viability of FDG-mNP and 
fasentin treated spheroids 
As shown in Figure 5, as seen on images 
obtained with the EVOS XL microscope, the 
spheroid treated with both FDG-mNPs and 
fasentin showed unchanged morphology 
compared with the untreated spheroid; 
however, the spheroid treated with only FDG-
mNPs showed changed morphology. When 
quantitative morphological parameters were 
assessed, the spheroid treated with only FDG-
mNPs showed a larger decrease in SI, 
roundness, and solidity than the spheroid 
treated with both fasentin and FDG-mNPs. 
There was not enough data to detect significant 
differences in quantitative parameters using 
two-way ANOVA. 
 
Figure 5. Analysis of morphological changes to NCI-H727 spheroids after treatment with FDG-MNPs 
and fasentin, a GLUT-1 inhibitor. A) Spheroids with an appropriate sphericity index (SI) were 
selected and treated with FDG-mNPs, with or without fasentin 24 hours prior to FDG-mNP treatment, 
and an EVOS XL microscope was used to obtain images. Scale bar 1000 um. B) Spheroids were 
reconstructed using the ReVISP software (https://sourceforge.net/projects/revisp/). C) 
Quantitative morphological information of the spheroids, including SI index, roundness, and solidity. 
ImageJ software (https://imagej.net/) was used along with Macro S1 for the calculation of 
morphological parameters. Samples labeled as “control” received no treatment, samples labeled as 
“FDG-MNPs” were treated with FDG-mNPs only, and samples labeled as “fasentin” were treated with 
fasentin prior to FDG-mNP treatment 
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When evaluating cell viability changes in 
spheroids when treated with FDG-mNPs with or 
without fasentin, exposure of NCI-H727 cells to 
0.3 mg/mL FDG-mNPs with and without 
fasentin decreased CTCF, confirming that there 
are fewer viable cells for treated cells compared 
with untreated cells (Figure 6). The reason that 
CTCF values are negative for both Hydroxy 
Dynasore and FDG-mNP might be the under- or 
over-exposure of the fluorescence images.  
 
Figure 6. Fluorescence microscopy of NCI-H727 and Corrected Total Cell Fluorescence (CTCF). NCI-
H727 cells were cultured for 24 hours to allow formation of spheroids and were treated with A) FDG-
mNPs only or B) FDG-mNPs and fasentin. The resulting spheroids were stained with propidium 
iodide solution (nucleus of dead cells appear red) in 100 mL of media for 10 minutes. Images were 
acquired using a Widefield microscope at 493 nm. C) CTCF was calculated using Area×Intensity 
Density−Background taken from using ImageJ software 
Advantage of Conjugating FDG with mNPs to 
Cause Apoptosis in Cancer Cells 
Glucose is a vital nutrient in maintaining 
tumor growth. It mediates signalling that leads 
to tumor progression. In this study, FDG-mNPs 
solubilised in PBS decreased cell viability of 
NCI-H727 and SH-SY5Y cells. This is in line with 
previous reports of the potential of FDG-mNPs 
to cause apoptosis in cancer cells. For example, 
we previously reported [7] that FDG-mNPs 
mediated neuroblastoma cytotoxicity in 
conjunction with alternating current magnetic 
field exposure. In another study, Roa et al. 
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reported that use of 6-FDG covalently bound to 
gold nanoparticles caused apoptosis in MCF-7 
adenocarcinoma cells and the combination of 6-
FDG with radiation increased cell death [24]. 
Similar to Roa et al, Hu et al found that the use 
of glucose-coated gold nanoparticles combined 
with X-ray exposure resulted in a greater 
targeted cancer destroying effect [25].  
Apoptosis is caused by caspases, a group of 
intracellular cysteine proteases. There are 
many pathways that have been studied but only 
a few have been studied extensively. One of 
these pathways is the tumour necrosis factor 
(TNF) pathway. TNF receptors trigger caspases 
as a signalling mechanism resulting in binding 
to the cell surface, thus inducing apoptosis. The 
extrinsic pathway is mediated by members of 
the TNF family. This includes Fas which 
employs adapter (Fadd) proteins in the 
cytosolic death domain involving bound pro-
caspases such as pro-caspase-8. The intrinsic 
pathway can be mediated by the release of 
mitochondrial cytochrome c due to increased 
levels of pro-apoptotic proteins such as Bax. The 
binding of cytochrome c triggers Apaf-1 
activation permitting it to bind to pro-caspase-
9 [26]. Once activated, caspase-9 and capsase-8 
will trigger caspase-3 (effector protease). This 
is an oversimplification of the intricacies that 
take place within the cells.  
FDG-mNPs and endocytosis  
Research has shown that nanoparticles of 
about 25 nm can be easily engulfed via the 
clathrin-dependent endocytic pathway within 
20 minutes [27] based on theoretical models. 
The FDG-mNPs used in this study were 10–20 
nm in size; therefore, they should have been 
transported in via the clathrin-dependent 
endocytic pathway. However, our results show 
that only a small amount of FDG-mNPs used the 
clathrin-dependent endocytic pathway. The 
nanoparticles that were transported, however, 
did manage to significantly change the 
morphology of the NCI-H727 spheroids, as seen 
by the reduction in roundness to 0.70 and the SI 
to 0.50.  
Our results suggest that FDG-mNPs may 
favor GLUT transporters as they are crosslinked 
with FDG. An alternative experiment to carry 
out would be to use a variety of GLUT receptors 
to find out which receptors the FDG-mNPs favor 
the most. GLUT receptors in cancer have been 
extensively studied and the experiment will 
either match the published literature or 
disprove it.  
2D vs 3D culture  
Standard 2D cell culture requires a flat 
surface for cells to adhere to. 2D cell cultures 
have homogenous growth due to an even 
amount of growth factors and nutrients found in 
the media. This makes 2D cell cultures one of 
the most commonly used platforms in the 
scientific field. However, in some instances, 2D 
cell culture will deviate from how the 
environment is in vivo. This is one reason that 
2D cell culture is not adequate for drug 
screening or delivery. In 1970, Sutherland et al. 
proposed the idea of spheroids to investigate 
cancers [28] and recently, 3D cell culture has 
been gaining interest for drug screening and 
delivery. The most vital characteristic of 3D cell 
culture that makes it an attractive platform is its 
ability to mimic the native environment of in 
vivo cells.  
Conclusions 
FDG-mNP was demonstrated to have 
cytotoxic effects on NCI-H7272 and SY5Y cancer 
cells. Concentrations of 0.075 mg/mL, 0.15 
mg/mL, and 0.3 mg/mL decreased mean cell 
viability of NCI-H727 cancer cells to 92.5%, 
82.9%, and 75%, respectively. FDG-mNPs were 
shown to have detrimental effects on the 
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viability of SY5Y cells: a decrease of 5.7%, 
18.6%, and 36.4% was found for SY5Y cells 
treated with 0.075 mg/mL, 0.15 mg/mL, and 0.3 
mg/mL concentrations of FDG-mNPs, 
respectively. We therefore conclude that FDG-
mNPs are promising in the development clinical 
applications for the destruction of cancer cells.  
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